Validation of molecular pathways in urgency urinary incontinence

Validation of molecular pathways in urgency urinary incontinence - Validation of molecular pathways in UUI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49318

Enrollment

Registered

2020-12-08

Start date

2021-03-03

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

involuntary leakage of urine urinary incontinence

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years or older Diagnosed with urgency urinary incontinence Requiring cystoscopy under anesthesia

Exclusion criteria

Exclusion criteria: Patients who will or cannot give informed consent (including language barriers) Patients who are pregnant or actually trying to conceive (i.e. active in fulfilling pregnancy wish)

Design outcomes

Primary

Measure	Time frame
Validation of the significant genes or molecular pathways derived from a molecular landscape on UUI and to perform in vitro tests of possible drug targets.	—

Secondary

Measure	Time frame
It is expected that, during the study period, more hypotheses will be formulated. They also need to be validated with in vitro assays.	—

Countries

Netherlands

Outcome results